Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

651 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A balance of interleukin-12 and -23 in cancer.
Ngiow SF, Teng MW, Smyth MJ. Ngiow SF, et al. Among authors: smyth mj. Trends Immunol. 2013 Nov;34(11):548-55. doi: 10.1016/ Epub 2013 Aug 13. Trends Immunol. 2013. PMID: 23954142 Review.
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. Nat Immunol. 2002 Jan;3(1):83-90. doi: 10.1038/ni746. Epub 2001 Dec 17. Nat Immunol. 2002. PMID: 11743585
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Cretney E, et al. Among authors: smyth mj. J Immunol. 2002 Feb 1;168(3):1356-61. doi: 10.4049/jimmunol.168.3.1356. J Immunol. 2002. PMID: 11801676
Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI. Smyth MJ, et al. Blood. 2002 Feb 15;99(4):1259-66. doi: 10.1182/blood.v99.4.1259. Blood. 2002. PMID: 11830474
NKT cells - conductors of tumor immunity?
Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI. Smyth MJ, et al. Curr Opin Immunol. 2002 Apr;14(2):165-71. doi: 10.1016/s0952-7915(02)00316-3. Curr Opin Immunol. 2002. PMID: 11869887 Review.
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. Seki N, et al. Among authors: smyth mj. J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484. J Immunol. 2002. PMID: 11907109
A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. J Immunol. 2002 May 1;168(9):4472-9. doi: 10.4049/jimmunol.168.9.4472. J Immunol. 2002. PMID: 11970991
Suppression of lymphoma and epithelial malignancies effected by interferon gamma.
Street SE, Trapani JA, MacGregor D, Smyth MJ. Street SE, et al. Among authors: smyth mj. J Exp Med. 2002 Jul 1;196(1):129-34. doi: 10.1084/jem.20020063. J Exp Med. 2002. PMID: 12093877 Free PMC article.
TNF contributes to the immunopathology of perforin/Fas ligand double deficiency.
Cretney E, Street SE, Smyth MJ. Cretney E, et al. Among authors: smyth mj. Immunol Cell Biol. 2002 Oct;80(5):436-40. doi: 10.1046/j.1440-1711.2002.01108.x. Immunol Cell Biol. 2002. PMID: 12225379
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Haynes NM, et al. Among authors: smyth mj. Blood. 2002 Nov 1;100(9):3155-63. doi: 10.1182/blood-2002-04-1041. Blood. 2002. PMID: 12384413
651 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page